Public Library of Science
Browse
Figure_3.tif (791.1 kB)

Combinations of either NVP-BKM120 and rapamycin or LY294002 and rapamycin in H2170 (left) and SW900 (right) lung cancer cell lines.

Download (0 kB)
figure
posted on 2012-02-15, 00:45 authored by Christopher R. Zito, Lucia B. Jilaveanu, Valsamo Anagnostou, David Rimm, Gerold Bepler, Sauveur-Michel Maira, Wolfgang Hackl, Robert Camp, Harriet M. Kluger, Herta H. Chao

Cells were treated with descending nanomolar concentrations of the PI3K inhibitor NVP-BKM120 or LY294002, alone or combined with 1 nM, 10 nM or 100 nM rapamycin for 72 hours and viability was measured with the Cell Titer Glo assay. The bars show viability as a percentage of viable cells relative to untreated cells. Three separate experiments were performed and each condition was measured in three replicate wells.

History

Usage metrics

    PLOS ONE

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC